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Extracellular vesicles (EV) can modulate the responses of cells to toll-like receptor (TLR) 
ligation; conversely, TLR ligands such as double-stranded RNA (dsRNA) can enhance 
the release of EV and influence of the composition and functions of EV cargos. Inflamed 
synovial joints in rheumatoid arthritis (RA) are rich in EV and extracellular RNA; besides, 
RNA released from necrotic synovial fluid cells can activate the TLR3 signaling in synovial 
fibroblasts (SFs) from patients with RA. Since EV occur prominently in synovial joints in 
RA and may contribute to the pathogenesis, we questioned whether EV can interact 
with dsRNA, a TLR3 ligand, and modify its actions in arthritis. We have used as model 
the effects on RA SFs, of EV released from monocyte U937 cells and peripheral blood 
mononuclear cells upon stimulation with Poly(I:C), a synthetic analog of dsRNA. We show 
that EV released from unstimulated cells and Poly(I:C)-stimulated U937 cells [Poly(I:C) 
EV] differ in size but bind similar amounts of Annexin V and express comparable levels of 
MAC-1, the receptor for dsRNA, on the vesicular membranes. Specifically, Poly(I:C) EV 
contain or associate with Poly(I:C) and at least partially protect Poly(I:C) from RNAse III 
degradation. Poly(I:C) EV shuttle Poly(I:C) to SFs and reproduce the proinflammatory and 
antiviral gene responses of SFs to direct stimulation with Poly(I:C). Poly(I:C) EV, however, 
halt the death receptor-induced apoptosis in SFs, thereby inverting the proapoptotic 
nature of Poly(I:C). These prosurvival effects sharply contrast with the high toxicity of 
cationic liposome-delivered Poly(I:C) and may reflect the route of Poly(I:C) delivery via EV 
or the fine-tuning of Poly(I:C) actions by molecular cargo in EV. The demonstration that 
EV may safeguard extracellular dsRNA and allow dsRNA to exert antiapoptotic effects on 
SFs highlights the potential of EV to amplify the pathogenicity of dsRNA in arthritis beyond 
inflammation (by concurrently enhancing the expansion of the invasive synovial stroma).
Keywords: double-stranded rna, extracellular vesicles, Poly(i:c), synovial fibroblasts, inflammation, apoptosis, 
innate immunity
inTrODUcTiOn
Extracellular vesicles (EV) are a heterogeneous group of vesicles that are secreted from cells to enter 
the extracellular space where they can exhibit a variety of immunological properties. EV vary in size, 
mechanisms of biogenesis, and molecular composition of vesicular membranes and intravesicular 
cargos, including a variety of lipids, proteins, and nucleic acids (1). The structure of EV can stabilize 
of vesicular cargos and thereby allows EV to act in intercellular communication and the transfer of 
2Frank-Bertoncelj et al. EV Modify the Actions of Poly(I:C)
Frontiers in Immunology | www.frontiersin.org January 2018 | Volume 9 | Article 28
informational molecules in vivo over varying distances (2). EV 
control fundamental cellular functions such as cellular migration, 
invasion, and immune responses (2, 3) and have a prominent 
role in human diseases, functioning as drivers of disease, disease 
biomarkers, or potential therapeutics (2, 3).
EV are increasingly recognized for their potentially important 
roles in the pathogenesis of autoimmune diseases, including 
rheumatoid arthritis [RA] (3, 4). Synovial fluid from patients 
with RA contains increased amounts of EV derived from plate-
lets, monocytes, lymphocytes and neutrophils (5–8). These EV 
can promote the matrix-degrading and/or proinflammatory 
properties in synovial fibroblasts (SFs) and/or neutrophils (5, 6, 
9, 10), thereby aggravating the arthritis; EV, however, can have 
also chondroprotective (7) and proresolving (11) functions, 
which could be exploited therapeutically (4). EV contain or can 
associate with proinflammatory cytokines (5), damage-associated 
molecular patterns (DAMPs) (11), or citrullinated autoantigens 
(6, 12) and can modulate their proinflammatory actions (6, 13) in 
inflammatory arthritis.
Signaling via toll-like receptors (TLRs) is central to the innate 
immune responses and the pathogenesis of autoimmune diseases, 
including RA (14). TLR ligands such as polyinosinic-polycytidylic 
acid [Poly(I:C)] can enhance the release of EV from a diversity of 
cell types that populate the synovium in RA (9) and can specify 
the composition and function of EV cargos (15). Conversely, EV 
can influence the responses of cells to TLR ligation (16). Poly(I:C) 
is a synthetic analog of double-stranded RNA (dsRNA) that 
activates the signaling via TLR3 and cytoplasmic dsRNA sensors 
such as melanocyte differentiation-associated 5 (MDA5, also 
known as IFIH1) (17, 18). Poly(l:C) is used to model the actions 
of extracellular dsRNA. Extracellular dsRNA is released in vivo 
from injured tissues and dying cells and can aggravate tissue dam-
age via TLR3-dependent mechanisms (19). Synovial tissues from 
patients with RA contain increased amounts of extracellular RNA 
(20) and are rich in the expression of TLR3 (21). RNA released 
from necrotic synovial fluid cells activates the proinflammatory 
signaling via TLR3 in SFs, the key effector cells in joint inflam-
mation and destruction in RA (22). Besides, stimulation of SFs 
with Poly(I:C) recapitulates the cytokine composition of synovial 
fluid in RA (23).
Since EV and extracellular RNA share the common extra-
cellular space in inflamed synovial joints of patients with RA, 
they may interact to influence the functions of each other, 
thereby contributing distinctly to the activation of SFs and the 
pathogenesis of inflammatory arthritis. Here, we show that EV 
released from monocyte U937 cells stimulated with Poly(I:C) 
incorporate Poly(I:C) into their structure, at least partially 
protect Poly(I:C) from RNAse degradation and shuttle Poly(I:C) 
to SFs from patients with RA. While Poly(I:C)-containing EV 
could recapitulate the antiviral and proinflammatory effects of 
Poly(I:C) in RA SFs, these EV inverted the proapoptotic actions 
of Poly(I:C), thereby protecting SFs from death receptor-induced 
apoptosis. In sum, these findings suggest that the EV-rich milieu 
of inflamed synovial joints in RA fosters the pathogenicity of 
dsRNA by guarding the integrity of dsRNA and diversifying its 
actions beyond the effects of free dsRNA.
MaTerials anD MeThODs
cell culture
Human U937 cells (Leibniz Institute DSMZ-German Collection 
of Microorganisms and Cell Cultures) were maintained in RPMI 
1640 cell culture medium (Gibco by Life Technologies) supple-
mented with 10% fetal calf serum (FCS). U937 cells of passages 
8–40 were used in the experiments. Human SFs were derived from 
synovial tissues of RA patients obtained during joint replacement 
surgery at the Schulthess Clinic, Zurich, Switzerland. All patients 
fulfilled the American College of Rheumatology 1987 criteria 
for RA (24). SFs were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM, Gibco by Life Technologies) supplemented 
with 10% FCS and SFs of passages 4–8 were used in the experi-
ments. For preparation of the cell culture media, FCS was heat 
inactivated at 56°C and was sterile filtered (0.22 µm). Cell cultures 
were negative for mycoplasma contamination as assessed by 
MycoAlert mycoplasma detection kit (Lonza).
Peripheral blood mononuclear cells (PBMCs) were isolated 
from peripheral blood of healthy donors (n  =  3) by density 
gradient centrifugation using Ficoll-Paque™ according to manu-
facturer’s recommendations (Milteny Biotec). PBMCs were 
maintained in RPMI 1640 supplemented with 10% FCS in the 
presence or absence of Poly(I:C) for 16  h. For flow cytometry 
measurements of MAC-1 expression PBMCs were isolated from 
healthy donors using also the Ficoll-Percoll method as described 
in previous studies (25, 26).
Treatment of U937 cells and PBMcs and 
Preparation of eV
U937 cells and PBMCs were stimulated with 20  µg/ml high-
molecular-weight Poly(I:C) [Poly(I:C) HMW, InvivoGen] for 
16 h or were left untreated. EV were isolated from the conditioned 
media of 15 million U937 cells using differential centrifuga-
tion protocol. Cells were pelleted at 360  g, 6  min, RT, and the 
supernatants were centrifuged at 1,400 g, 10 min, RT to remove 
cell debris. Cell- and cell debris-free supernatants (~8 ml) were 
then centrifuged at 20,000 g, 4°C, 20 min to obtain EV pellets. 
EV pellets were washed in two subsequent centrifugation steps 
(20,000 g, 4°C, 20 min) with Dulbecco’s phosphate-buffered saline 
(DPBS, Gibco by Life Technologies) and finally resuspended in 
DMEM supplemented with 0.5% FCS. The supernatant from the 
last washing step of EV pellets (control Sup) served as a negative 
control for a potential carryover of residual soluble Poly(I:C) 
or soluble U937 cell-derived mediators via EV suspensions. 
Additionally, sterile filtered (220 nm filter) RPMI 1640 medium 
containing 10% FCS was incubated with 20  µg/mL Poly(I:C) 
for 16  h under the same conditions as cells. This medium was 
differentially centrifuged as described above to pellet potential 
residual FCS-derived EV (remaining after sterile filtering the cell 
culture media through 0.22 µm filters, a standard step during cell 
culture media preparation in our laboratory). FCS EV control 
samples were used in stimulation experiments to determine 
whether potential residual FCS-derived EV are responsible for 
the observed effects of Poly(I:C) EV. In a subset of experiments 
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15 million U937 cells were incubated with 100 ng/ml LPS from 
Escherichia coli J5 (List Biological Laboratories, # 301) or 10 ng/
ml of recombinant human TNF alpha (R&D Systems, # 210-TA) 
and LPS EV or TNF EV, respectively, were isolated according to 
the protocol described above. The control Sup obtained from the 
last washing step of LPS EV pellets increased the expression of 
IL-6 mRNA in SFs, pointing toward the potential LPS contamina-
tion in control Sup and LPS EV. Thus, we used only TNF EV in 
further analyses.
characterization of eV
Size distribution and number of EV were determined by nano-
particle tracking analysis (NTA) using NanoSight LM10 
Instrument (NanoSight Ltd., number of tracks 322–772, tempera-
ture 28.8–28.9°C, viscosity 0.82 cP, 30 frames/s, time 60 s). NTA 
enables automatic tracking and sizing of particles based on their 
Brownian motion and diffusion coefficient, thereby measuring an 
absolute concentration of particles and the frequency distribution 
of particle sizes. For NTA, EV pellets derived from 15 × 106 U937 
cells (n =  2 per condition) were resuspended in sterile filtered 
DPBS and diluted 1:10. Undiluted FCS EV samples showed 
minimal contamination with particles, accounting for ~1% of all 
particles in media conditioned with cells.
In addition to NTA, EV were analyzed on FACSCanto II 
or FACSCalibur flow cytometers (BD Biosciences) using BD 
FACSDIVA or FlowJo V10, respectively. The settings for EV analysis 
were established with the Megamix fluorescent beads (Biocytex) 
according to the manufacturer’s protocol. EV were labeled with PE 
Mouse Anti-Human CD11b/Mac-1 (BD Pharmingen, #555388, 
2.5  µg/ml), PE Mouse IgG1 κ Isotype control (BD Pharmingen, 
#555749, 2.5  µg/ml) or FITC-Annexin V (5  µl per sample, BD 
Pharmingen, 556419) for 15  min at RT in the dark, thoroughly 
washed and analyzed by flow cytometry.
The total amount of protein in EV pellets derived from 15 
million U937 cells (lysed in 50 µl RIPA buffer) was determined 
spectrophotometrically using the Pierce™ BCA Protein Assay 
Kit (Thermo Fisher Scientific) according to the manufacturer’s 
instructions.
Treatment of sFs
During coculture experiments with EV, SFs were maintained in 
DMEM supplemented with 0.5% FCS. 100,000 SFs were stimulated 
with EV derived from 3 × 106 untreated or Poly(I:C)-stimulated 
U937 cells for 24 h. A set of negative control experiments included 
treatment of SFs with control Sup and FCS EV controls. SFs were 
directly stimulated with HMW Poly(I:C) (20 pg/ml to 20 μg/ml, 
InvivoGen, # tlrl-pic-5) or were transfected with HMW Poly(I:C) 
(0.02–1  µg/ml, InvivoGen, # tlrl-pic-5) using Lipofectamine 
2000 (Invitrogen) according to manufacturer’s instructions. 
Apoptosis was induced in SFs with 200  ng/ml of recombinant 
human TNF-related apoptosis-inducing ligand (TRAIL) (R&D 
Systems, #375-TEC) or with 100 ng/ml human recombinant Fas 
ligand (FasL) (R&D Systems, #126-FL) in the absence or pres-
ence of Poly(:C) EV, Con EV, TNF EV or Sup controls. SFs were 
treated with TRAIL and directly stimulated with HMW Poly(I:C) 
(20pg/ml-20μg/ml, InvivoGen, # tlrl-pic-5) or transfected with 
HMW Poly(I:C) (0.02–1  µg/ml, InvivoGen, # tlrl-pic-5). To 
inhibit the NF-kB signaling, sc-514 (50 µM, EMD Millipore) was 
diluted in DMSO (Sigma) and added to the cell culture medium 
1 h before treatment of SFs with EV in the presence or absence 
of TRAIL. DMSO, containing no sc-514 was used as a control. 
The efficacy of sc-514 (50 µM, EMD Millipore) in inhibiting the 
NF-kB signaling was tested in SFs, stimulated with 10 ng/ml TNF 
alpha (R&D Systems, # 210-TA) for 24 h.
reportergene assay
To measure NF-κB activity, SFs were transfected with 1.2  µg 
of pRL_GAPDH plus 1.8  µg of pGL4.32[luc2P/NF-κB-RE/
Hygro] vector (Promega) or pGL4.27[luc2P/minP/Hygro] vec-
tor (Promega), using Nucleofector technology (Amaxa/Lonza). 
At 24  h after transfection, SFs were stimulated with EV in the 
presence or absence of 200 ng/mL TRAIL for 6 h, detached with 
trypsin and lysed in 1× Passive Lysis Buffer (Promega). Firefly 
luciferase activity was measured with a Dual Luciferase Reporter 
Assay System (Promega) and normalized to the activity of Renilla 
luciferase.
Quantitative real-time Polymerase chain 
reaction
Total RNA was isolated from SFs and U937 cells using miRNe-
asy Mini Kit (Qiagen) including on-column DNase I (Qiagen) 
digestion. 300  ng of total RNA was reverse transcribed using 
Random Hexamers and MultiScribe Reverse Transcriptase 
(Applied Biosystems/Thermo Fisher Scientific). The expres-
sion of proinflammatory genes (IL-6, IL-8) and antiviral genes 
[MDA5, retinoic acid-inducible gene 1 (RIG-I), TLR3, interferon 
beta (IFNB)] was measured by SYBR Green or TaqMan qPCR 
(7500 or 7900HT real-time PCR systems, Life Technologies) 
with normalization to 18S rRNA, glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) or hypoxantine-guanine phosphoribo-
syltransferase (HPRT1) as indicated in respective figure legends. 
No template control samples, dissociation curves and samples 
containing the untranscribed RNA were measured in parallel. 
The primer sequences are given in Table S1 in Supplementary 
Material; except primers for 18S rRNA and IFNB (Applied 
Biosystems). The expression of target mRNAs was determined 
using the comparative threshold cycle method as described in 
Ref. (27).
enzyme-linked immunosorbent assay
The secretion of IL-6 and IL-8 into supernatants of SFs was meas-
ured with the human IL-6 and IL-8 ELISA sets (BD Biosciences), 
according to the manufacturer’s instructions.
The association of Poly(i:c) with U937 
cells and U937 cell-Derived eV
To study the surface binding and internalization of Poly(I:C) into 
U937 cells and their cognate EV, 750,000 U937 cells were stimu-
lated with 5  µg/ml Poly(I:C) HMW Fluorescein (InvivoGen, # 
tlrl-picf) or 5  µg/ml Poly(I:C) HMW Rhodamine (InvivoGen, 
# tlrl-picr) for 16 h. U937 cells and EV pellets were thoroughly 
washed and the presence of fluorescently labeled Poly(I:C) was 
measured by FACSCalibur flow cytometer (BD Biosciences). To 
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assess whether Poly(I:C) can directly interact with EV, conditioned 
medium from unstimulated U937 cells was centrifuged to remove 
cells and cellular debris. Cell-free medium, containing Con EV 
was then incubated with 5  µg/ml Poly(I:C) HMW Rhodamine 
(InvivoGen, # tlrl-picr) for 120 min, 37°C, 5% CO2 followed by 
the isolation of EV and detection of Rhodamine Poly(I:C) by 
FACSCalibur flow cytometer (BD Biosciences).
To determine whether “vesicular” Poly(I:C) can be degraded 
by RNase, U937 cell-derived Fluorescein Poly(I:C) EV and Con 
EV, preincubated with Rhodamine Poly(I:C), were digested with 
RNase III (E. coli, Applied Biosystems/Ambion) for 2 h at 37°C 
according to the manufacturer’s protocol. Additionally, Poly(I:C), 
Rhodamine Poly(I:C) and Fluorescein Poly(I:C) were digested in 
tube with RNase III (E. coli, Applied Biosystems/Ambion) for 2 h 
at 37°C according to the manufacturer’s protocol. The efficiency 
of digestion of “vesicular” and “soluble” Poly(I:C) was assessed 
by flow cytometry (FACSCalibur, BD Biosciences) and agarose 
gel electrophoresis (using 1kB GeneRuler DNA ladder, Thermo 
Fisher Scientific). For flow cytometry analysis, 10 µg/ml of HMW 
Fluorescein Poly(I:C) was digested by 0.2 U/μl RNAse III.
Transfer of Poly(i:c) to sFs via eV
To study the transfer of Poly(I:C) to SFs via EV, SFs were treated 
for 24 h with EV released from U937 cells upon stimulation with 
5  µg/ml Poly(I:C) HMW Rhodamine or Poly(I:C) HMW 
Fluorescein. SFs were treated also with the Sup from the last 
washing of EV pellets or were stimulated with 5 µg/ml Rhodamine 
Poly(I:C) or 10 µg/ml Fluorescein Poly(I:C) for 24 h.
The presence of fluorescently-labeled Poly(I:C) in SFs was 
determined by flow cytometry and confocal microscopy. For 
flow cytometry, SFs were detached using the accutase, thoroughly 
washed with DPBS and immediately analyzed by FACSCalibur 
flow cytometer (BD Biosciences).
For confocal microscopy SFs, cultured in chamber slides 
(Lab-Tek; Nunc), were thoroughly washed with DPBS and 
fixed with 4% paraformaldehyde for 20 min RT. The slides were 
blocked with 1% bovine serum albumin/5% human serum for 
40 min and incubated with FITC Mouse Anti-Human CD90 (BD 
Pharmingen, # 555595, 10  µg/ml, CD90 is a fibroblast surface 
marker) or FITC Mouse IgG1 κ isotype control antibodies (BD 
Pharmingen, # 555748, 10 µg/ml) for 1 h at RT. The nuclei were 
stained with DAPI (Sigma-Aldrich). Slides were covered with 
fluorescence mounting medium (Dako Cytomation). The images 
were taken by confocal laser scanning microscope Leica SP5 (Leica 
Microsystems) using the LAS AF software (Leica Microsystems).
Flow cytometry analysis of U937 and 
PBMcs
U937 cells and PBMCs were analyzed on FACSCalibur flow 
cytometer (BD Biosciences). Fc receptors were preblocked with 
10% FCS-containing DPBS for 30 min, 4°C. Cells were labeled 
with PE Mouse Anti-Human CD11b/Mac-1 (BD Pharmingen, 
#555388, 10  µg/ml), PE Mouse Anti-Human CD14 (BD 
Pharmingen, # 555398, 10 µg/ml) or PE Mouse IgG1 κ Isotype 
control (BD Pharmingen, #555749, 10 µg/ml) for 45 min, 4°C in 
the dark, thoroughly washed and analyzed.
Western Blot
Cells were lysed in ice cold RIPA buffer and the insoluble material 
was removed by centrifugation at 12,000 g, 10 min. Whole cell 
lysates were separated on 10% SDS-polyacrylamide gels and elec-
troblotted onto nitrocellulose membranes (Amersham Protran, 
GE Healthcare). Membranes were blocked in 5% (weight/vol-
ume) nonfat milk in TBS-T (20 mM Tris base, 137 mM sodium 
chloride, 0.1% Tween 20, pH 7.6) for 1  h. Western blots were 
performed using rabbit anti Caspase 3 antibodies (Cell Signaling, 
#9662, 1:1,000), which detect both cleaved and uncleaved forms 
of caspase 3, and mouse anti α-tubulin antibodies (Abcam, 
#ab7291, 1:10,000). Secondary antibodies conjugated with 
horseradish peroxidase were from Jackson ImmunoResearch 
(#111-036-047 and #115-036-062, 1:10,000). Protein bands were 
visualized using the enhanced chemiluminescence Western blot 
detection reagent (GE Healthcare) and the Fusion Fx Imager/
Fusion software (Vilber Lourmat). Densitometry analysis of 
protein bands was carried out using the Bio-ID software (Vilber 
Lourmat). For quantification of Western blots, the levels of 
cleaved caspase 3 were normalized to the levels of uncleaved 
caspase 3.
annexin V apoptosis assay
U937 and SFs were washed with DPBS and 1 × 106 cells/ml were 
resuspended in Annexin V binding buffer (BD Biosciences). 
Cells were labeled with FITC Annexin V (5 µl, BD Pharmingen, 
#556419) and propidium iodide (PI, Sigma-Aldrich) in the dark 
for 15 min, RT and analyzed by flow cytometry (FACSCalibur; 
BD Biosciences). Cells stained with Annexin V alone, PI 
alone and unstained cells were used to set up flow cytometry 
settings.
statistical analysis
Data were analyzed with GraphPad Prism version 7.0. The 
distribution of data was tested with Kolmogorov–Smirnov and 
D’Agostino and Pearson omnibus normality tests for small and 
large samples, respectively. Multiple group comparisons were 
performed by one-way ANOVA with Tukey’s, Dunnett’s, or 
Sidak’s multiple comparisons tests (normal distribution) with 
or without Geisser–Greenberg correction for unequal spheric-
ity or Friedmann test with Dunn’s multiple comparisons test 
(distribution not normal). Paired samples were compared with 
two-tailed paired t-test (normally distributed data) or Wilcoxon 
signed rank test (distribution not normal). P-value <0.05 was 
considered statistically significant. Heatmaps of experimental 
data (details provided in respective figure legends) were produced 
with Shiny by R Studio, developed by Functional Genomics Center 
Zurich, University of Zurich and ETH Zurich, Switzerland, using 
row scaling transformation of data.
resUlTs
characterization of U937 cell-Derived eV
We analyzed the size distribution and the amount of EV released 
from U937 cells using the NTA. NTA efficiently detects particles 
with diameters up to 1 µm, whereas Brownian motion of larger 
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particles such as apoptotic bodies is slower and they are less 
readily detected (28). Our differential centrifugation protocol 
should predominantly isolate EV in the size range of microvesi-
cles (0.1–1 μm) (29) while lacking exosomes (50–100 nm) that 
sediment at high centrifugation forces. Our protocol should 
also deplete apoptotic bodies (1–5 μm) (29) through a precen-
trifugation step at 1,600  g (30, 31). Accordingly, particles with 
sizes of microvesicles predominated in the EV preparations 
from unstimulated U937 cells (Con EV) [Figure  1A, median 
(10th, 90th percentile): 218  nm (114, 371  nm) and 227 (131, 
368 nm), n = 2] and Poly(I:C)-stimulated U937 cells [Poly(I:C) 
EV] [Figure 1B, 346 nm (217, 504 nm) and 287 (187, 413 nm), 
n = 2]. A prominent peak of smaller particles was present in Con 
EV pellets (Figure 1A). In all, these results suggested that Con EV 
and Poly(I:C) EV might differ in composition or origin.
As measured by NTA, Poly(I:C) EV pellets contained smaller 
amounts of particles (5.20 × 109/ml, 4.26 × 109/ml, n = 2) com-
pared with Con EV pellets (6.73 × 109/ml, 5.98 × 109/ml, n = 2). In 
contrast, the total protein content did not differ between Poly(I:C) 
EV and Con EV pellets (Figure 1C). Stimulation with Poly(I:C) 
increases the release of EV from different cell types as measured 
by flow cytometry (32, 33). Poly(I:C) enhances apoptosis in a 
variety of cell types (34, 35) including U937 cells (Figure S1A in 
Supplementary Material), thereby enriching cell supernatants 
for apoptotic vesicles, including apoptotic bodies. A depletion of 
apoptotic bodies by our protocol and their better visibility on flow 
cytometer could contribute to detecting the smaller amounts of par-
ticles in Poly(I:C) EV pellets by NTA compared with flow cytometry 
(32, 33). Alternatively, enhanced aggregation of particles in Poly(I:C) 
EV pellets might diminish the particle numbers and increase the 
particle size, while the total protein content would not change.
The International Society for Extracellular Vesicles set the 
guidelines on minimal experimental requirements for identifying 
EV, including the detection of phosphatidylserine and cell sur-
face markers on vesicular membranes (36). As detected by flow 
cytometry, U937 cell-derived Con EV and Poly(I:C) EV bound 
similar amounts of Annexin V (Figure 1D) and expressed similar 
levels of the U937 cell surface molecule MAC-1 (Figure 1E), also 
known as integrin subunit alpha M (ITGAM) or CD11B, which 
is a cell surface receptor for extracellular dsRNA (37). Untreated 
and Poly(I:C)-treated U937 cells expressed similar levels of 
MAC-1 on their surface (Figure S1B in Supplementary Material).
Altogether, these measurements showed that Poly(I:C) EV and 
Con EV differ in size while exhibiting similar Annexin V binding 
and MAC-1 expression on the surface.
Poly(i:c) eV Mimic the Proinflammatory 
and antiviral responses induced by 
Poly(i:c)
Previous studies have shown that immune cell-derived EV, 
including EV from U937 cells, released ex vivo upon stimulation 
with proinflammatory mediators, enhance the matrix-destructive 
and proinflammatory properties of SFs (9). Besides, a transfer of 
cellular RNA via EV was shown sufficient for inducing the NF-kB 
signaling in recipient human embryonic kidney 293T cells (38). 
Here, we demonstrate that SFs, cocultured with U937 cell-derived 
Poly(I:C) EV activated signaling through the NF-kB pathway 
(Figure  2A), which coincided with the increased expression 
of proinflammatory genes (Figures S2A,B in Supplementary 
Material) and the enhanced secretion of IL-6 (Figure 2B; Figure 
S2A in Supplementary Material) and IL-8 (Figure  2C; Figure 
S2B in Supplementary Material) proteins into cell culture media. 
By using a set of negative controls in our experiments, includ-
ing Sup controls (Figures 2B,C), FCS EV controls (Figure S2C 
in Supplementary Material), and Con EV (Figures  2B,C), we 
ruled out the carryover of soluble Poly(I:C) and U937-derived 
mediators via EV pellets, concluding thereby that the observed 
proinflammatory effects are specifically attri buted to Poly(I:C) 
EV.
Polymyxin B strongly inhibited the LPS-induced secretion of 
IL-6 from SFs (Figure S2D in Supplementary Material), but had 
a limited effect on the IL-6 secretion induced with Poly(I:C) EV 
(Figure 2B). This argued against the presence of contaminating 
LPS in Poly(I:C) EV pellets and rather suggested a possible mild 
negative effect of Polymyxin B on the integrity of vesicular mem-
brane (39). SFs cocultured with either Poly(I:C) EV or Poly(I:C) 
EV plus Polymyxin B clustered together based on the magnitude 
of their proinflammatory responses (Figures 2D,E), but clearly 
diverged from SFs treated with negative controls, which clustered 
together with untreated SFs (Figures 2D,E).
In addition to enhancing the proinflammatory responses, 
Poly(I:C) EV increased the expression of antiviral genes in SFs. 
The expression of genes such as IFNB, MDA5, and RIG-I was 
upregulated, while TLR3 mRNA expression remained rather 
unchanged as shown by the clustering of transcriptional responses 
in SFs upon Poly(I:C) EV coculture (Figure 2F) as well as gene 
expression measurements in a larger set of SFs (Figure 2G).
Collectively, these results demonstrated that gene expression 
changes in the presence of Poly(I:C) EV were largely reminiscent 
of the transcriptional activation of SFs with Poly(I:C) (23, 40, 41). 
These effects of Poly(I:C) EV on SFs could reflect the transfer 
of Poly(I:C)-induced molecules from U937 cells to SFs via EV 
as shown for ovarian carcinoma (HEY) cell-derived Poly(I:C)-
induced exosomes (15). Yet, we did not detect IL-6 mRNA in U937 
cells under our qPCR conditions and the levels of IL-8, MDA5, 
and RIG-I mRNAs in U937 cells did not alter upon Poly(I:C) 
stimulation (Figure S2E in Supplementary Material), indicating 
that both Con EV and Poly(IC) EV could shuttle these transcripts 
to SFs. The exclusive activation of SFs by Poly(I:C) EV thus sug-
gested that Poly(I:C) EV might capture and transfer Poly(I:C) to 
SFs, thereby activating the dsRNA signaling pathways.
U937 cell-Derived eV capture Poly(i:c)
Extracellular nucleic acids, such as dsDNA, readily associate with 
EV (42), and EV contain a diversity of small and long intracel-
lular RNA species (with lengths up to 4,000 bases) (30). Vesicular 
RNA can be transferred to recipient cells in cocultures and tissue 
microenvironments altering thereby recipient cell functions 
(38, 43, 44). Based on these studies, we speculated that EV could 
capture at least some of the HMW Poly(I:C) molecules (1.5–8 kb) 
and transfer them to SFs. To study the capturing of Poly(I:C) in 
vesicles, we stimulated U937 cells with Rhodamine Poly(I:C) or 
FigUre 1 | Characterization of U937 cell-derived extracellular vesicles (EV). Size distribution of particles (white line) and cumulative percentage of particles under 
given size (gray line) in EV preparations from (a) untreated U937 cells and (B) Poly(I:C)-stimulated U937 cells as detected by nanoparticle tracking analysis, shown is 
one of n = 2 biological replicates per condition. (c) Total protein amount in EV from untreated U937 cells (Con EV) and Poly(I:C)-stimulated U937 cells [Poly(I:C) EV] 
as measured by BCA Protein Assay, n = 8 biological replicates, mean ± SD. (D) Binding of FITC Annexin V to the surface of Con EV and Poly(I:C) EV with SSC-H/
FSC-H profile of EV and histogram of FITC-labeled Annexin V binding, shown is one sample of n = 3 biological replicates per condition. Percentage of Annexin 
V-positive EV as measured by flow cytometry. (e) The expression of MAC-1 on the surface of Poly(I:C) EV with SSC-H/FSC-H profile of EV and FL2 histogram of 
MAC-1 positivity, as measured by flow cytometry. Shown is one sample of n = 4 biological replicates per condition. Percentage of MAC-1-positive EV as measured 
by flow cytometry. Statistics: (c–e) two-tailed paired t-test, ns, not significant.
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Fluorescein Poly(I:C); we digested Poly(I:C) EV with RNAse III 
in a subset of experiments. We showed that fluorescently labeled 
Poly(I:C) was present in U937 cells (Figure S3A in Supplementary 
Material) and their cognate EV (Figure  3A; Figures S3B,C in 
Supplementary Material), and variable proportions of EV, as 
detected by flow cytometry, contained Poly(I:C) (Figure  3A; 
FigUre 2 | Continued
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Figures S3B,C in Supplementary Material). This finding is con-
sistent with recent studies showing the capture of Poly(I:C) as 
well as other TLR ligands in exosomes from dendritic cells that 
were exposed to Poly(I:C) or other TLR ligands (45, 46). We also 
analyzed soluble HMW Fluorescein Poly(I:C) by flow cytometry. 
This analysis demonstrated that vesicular and soluble fluorescent 
FigUre 2 | Extracellular vesicles (EV) derived from Poly(I:C)-stimulated U937 induce proinflammatory and antiviral responses in synovial fibroblasts (SFs). (a) The 
activity of NF-κB in synovial fibroblasts cocultured with EV derived from unstimulated U937 cells (Con EV) or Poly(I:C)-stimulated U937 cells [Poly(I:C) EV], as 
measured by a Dual Luciferase Reporter Assay System and expressed as x-fold induction compared to untreated cells, shown are biological replicates. Secretion of 
(B) IL-6 and (c) IL-8 proteins (pg/ml) into supernatants of synovial fibroblasts as measured by ELISA (biological replicates). Polymyxin B (PX) was used to control for 
LPS contamination. Supernatants from the last washing step of Poly(I:C) EV pellets (supernatants) were used to control for the carryover of soluble Poly(I:C) or 
U937-derived mediators. (D,e) Heatmaps show clustering of proinflammatory responses in synovial fibroblasts under different experimental conditions based on the 
IL-6 and IL-8 ELISA [see (B,c)]. (F) Heatmap demonstrates the clustering of antiviral gene responses in synovial fibroblasts cocultured with Poly(I:C) EV (qPCR, 
x-fold induction as compared with unstimulated cells, screening experiment with n = 2 biological replicates). (g) The expression of MDA5 and IFNB in synovial 
fibroblasts cocultured with Con EV or Poly(I:C) EV, qPCR data expressed as ΔCt with normalization to GAPDH and HPRT1, respectively, shown are biological 
replicates. In the screening experiment, MDA5 and IFNB showed variable induction upon coculture of synovial fibroblasts with Poly(I:C) EV and were thus measured 
in a larger cohort of synovial fibroblasts. Statistics: (a) Wilcoxon signed rank test, (B) one-way ANOVA with Tukey’s multiple comparison test and Geisser-
Greenhouse correction for unequal sphericity, (c) Friedmann test with Dunn’s multiple comparisons test, (g) one-way ANOVA with Tukey’s multiple comparisons test 
(IFNB), Friedmann test with Dunn’s multiple comparisons test (MDA5).
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Poly(I:C) have comparable median florescence intensities, but 
distinct forward/side scatter characteristics, which enables their 
discrimination by flow cytometry (Figure 3B). Specifically, solu-
ble Fluorescein Poly(I:C) was detected largely within cytometer 
noise and only few fluorescent events spilled into the EV flow 
cytometry window.
Extracellular RNA, present in EV, bound to cell surface 
molecules, or complexed with Argonaut proteins, can be pro-
tected from RNAse degradation (47–49). To investigate RNAse 
sensitivity of the EV-contained Poly(I:C) we used flow 
cytometry and showed that EV-contained Poly(I:C) is at least 
partially resistant to degradation with RNAse III (Figure 3B). 
In contrast, this nuclease could efficiently degrade soluble fluo-
rescent Poly(I:C) (Figures S3D,E in Supplementary Material). 
RNAse-digested soluble Fluorescein Poly(I:C) spilled to a 
greater extent into the EV flow cytometry window compared 
with nondigested soluble Fluorescein Poly(I:C) and was char-
acterized with a large (more than 15-fold) increase in median 
fluorescence intensity (MFI) compared to nondigested soluble 
Fluorescein Poly(I:C) (Figure  3B). In contrast, MFIs of 
vesicular Fluorescein Poly(I:C) increased only moderately 
and non-significantly in the presence of increasing concentra-
tions of RNase III (Figure  3B). This indicated that RNAse 
III-treated Fluorescein Poly(I:C) EV contained a limited 
amount of degraded Fluorescein Poly(I:C) and that EV at least 
partially protected Poly(I:C) from degradation with RNAse III. 
Additionally, we removed cells and cell debris from the cell 
culture media of unstimulated U937 cells via centrifugation 
and incubated the resulting cell-free media with fluorescently-
labeled Poly(I:C). These experiments showed that Poly(I:C) 
readily associated with Con EV in the cell-free media from 
unstimulated U937 cells (Figure  3C). MFI of vesicular Rho-
damine Poly(I:C) did not increase significantly in the presence 
of RNAse III (Figure 3C). This further demonstrated that in a 
complex with EV, Poly(I:C) was rather protected from RNAse 
III degradation (Figure 3C).
Collectively, these results demonstrated that Poly(I:C) can 
associate with EV, either trapped intravesicularly or bound to the 
vesicular surface in a manner that makes it rather resistant to 
RNase III degradation.
How cells sense and internalize extracellular dsRNA to signal 
through the intracellularly located dsRNA sensors is not com-
pletely understood (50). The cell surface receptor CD11b/CD18 
(Mac-1) is one of the sensors for extracellular Poly(I:C) and 
participates in Poly(I:C) internalization into mouse macrophages 
(37). We showed that MAC-1 was present on the surface of 
U937 cells (Figure S1B in Supplementary Material) and U937-
cell derived EV (Figure  1E). Similar amounts of MAC-1 were 
detected in unstimulated and Poly(I:C)-stimulated U937 cells 
(Figure S1B in Supplementary Material) as well as their cognate 
EV (Figure 1E). The presence of MAC-1 on U937 cells and EV 
suggested that MAC-1 may be one of the receptors contributing 
to the surface binding as well as trapping of Poly(I:C) within U937 
cells and their EV.
Poly(i:c) eV Transfer Poly(i:c) to sFs
Extracellular vesicles can transfer RNA between cells and thereby 
influence the recipient cell’s functions (43, 51). To explore whether 
EV can shuttle Poly(I:C) to SFs, we cocultured SFs with EV 
isolated from U937 that were stimulated with fluorescently 
labeled Poly(I:C). Additionally, SFs were directly treated with 
fluorescently-labeled Poly(I:C). As demonstrated by flow 
cytometry (Figure  4A) and fluorescence confocal microscopy 
(Figure  4B; Figure S4A in Supplementary Material), Poly(I:C) 
EV transferred Poly(I:C) to SFs. The distribution of Rhodamine 
Poly(I:C) differed in SFs stimulated with Poly(I:C) as compared 
with Poly(I:C) EV (Figure  4B; Figure S4A in Supplementary 
Material). The precise 3D localization (intra/extracellular) of 
vesicular Poly(I:C) was difficult to determine because of the flat 
fibroblast morphology (Figure S4A in Supplementary Material). 
Nevertheless, the recapitulation of Poly(I:C) responses by 
Poly(I:C) EV (Figure  2; Figure S2 in Supplementary Material) 
clearly showed that vesicular Poly(I:C) can efficiently induce 
Poly(I:C) responses in SFs. In these experiments, fluorescently 
labeled Poly(I:C) was not detected in SFs treated with Sup from 
the last washing step of Poly(I:C) EV (Figure  4A), thereby 
excluding potential carryover of soluble Poly(I:C) via EV pellets. 
Additionally, Fluorescein Poly(I:C) EV were readily detectable in 
the Sup of SFs at 24 h after starting the cocultures (Figure S4B in 
Supplementary Material), demonstrating the stability of vesicular 
Poly(I:C) in the extracellular space over time.
In summary, these results suggested that, in microenviron-
ments that contain extracellular dsRNA (e.g., endogenous dsRNA 
released from damaged tissues), monocyte-derived EV could play 
a prominent role in the intercellular shuttling of dsRNA and cel-
lular responses to extracellular dsRNA.
FigUre 3 | U937 cell-derived extracellular vesicles (EV) incorporate Poly(I:C) and may protect Poly(I:C) from degradation with RNase III. (a) The presence of 
Fluorescein Poly(I:C) in U937-derived EV. SSC-H/FSC-H and SSC-H/FL1 profiles of EV with percentage of gated events, as measured by flow cytometry. Shown are 
a representative sample of n = 3 biological replicates and quantification of flow cytometry data as percentage of Fluorescein Poly(I:C)-positive EV. Control EV (Con 
EV)-derived from untreated U937 cells. (B) Detection of soluble and vesicular Fluorescein Poly(I:C) digested or not with RNAse III. SSC-H/FSC-H profiles and FL1 
histograms of EV and Poly(I:C), as measured by flow cytometry. Shown is one of n = 3–4 biological replicates for EV and one of n = 2 replicates for soluble 
Fluorescein Poly(I:C). Quantification of changes in median fluorescence intensities (MFI) of vesicular and soluble Fluorescein Poly(I:C) in the presence and absence of 
RNAse III. (c) Association of control EV (Con EV) with Poly(I:C) or Rhodamine Poly(I:C) in the presence or absence of RNase III, as measured by flow cytometry, 
shown is one from n = 3 biological replicates. Quantification of MFI changes in Rhodamine Poly(I:C) EV in the presence of RNAse III. Statistics: (a,B) one-way 
ANOVA with Tukey’s multiple comparisons test, (c) two-tailed paired t-test, ns, not significant.
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FigUre 4 | U937 cell derived extracellular vesicles (EV) shuttle Poly(I:C) to synovial fibroblasts. (a) The presence of Fluorescein Poly(I:C) in synovial fibroblasts either 
cocultured with U937 cell-derived Fluorescein Poly(I:C) EV or Poly(I:C) EV, or treated with supernatants from the last washing step of the respective EV pellets or 
stimulated with Poly(I:C)/Fluorescein Poly(I:C). Sup were used to control for the contamination with soluble Poly(I:C). Shown are FL1 histogram of fluorescein 
fluorescence in a representative sample and quantification of changes in median fluorescence intensities (MFI) of synovial fibroblasts upon different treatments.  
(B) Confocal microscopy on synovial fibroblasts treated with Poly(I:C) or Rhodamine Poly(I:C) or cocultured with U937 cell-derived Poly(I:C) EV or Rhodamine 
Poly(I:C) EV for 24 h. Nuclei-DAPI (blue), FITC Mouse Anti-Human CD90 (green, fibroblast marker), Rhodamine Poly(I:C) (red). Magnification: 20× [Poly(I:C), 
Rhodamine Poly(I:C)] and 40× [Poly(I:C) EV, Rhodamine Poly(I:C) EV]. Statistics: (a) one way ANOVA with Sidak’s multiple comparison test and Geisser-Greenhouse 
correction for unequal sphericity.
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Poly(i:c) eV Deliver a Prosurvival signal 
during Death receptor induced-apoptosis
Poly(I:C) increases apoptosis of a variety of cell types (34, 35) 
including SFs (Figure S5A in Supplementary Material, in 
doses > 5 μg/ml). Intracellular delivery of very small amounts of 
Poly(I:C) by transfection with Lipofectamine 2000 was highly 
toxic for SFs (Figure S5B in Supplementary Material). In con-
trast, Poly(I:C) EV did not activate proapoptotic pathways in SFs 
(Figure 5A; Figure S5C in Supplementary Material). As estimated 
from the magnitude of MDA5 and IL-6 transcriptional responses 
of SF to direct stimulation with Poly(I:C) (Figures S5D,E in 
Supplementary Material), Poly(I:C) EV most likely transferred 
only a small amount of Poly(I:C) to SFs. Although these amounts 
were sufficient to induce the proinflammatory and antiviral 
responses, they might be too small to convey the proapoptotic 
effects of Poly(I:C).
Decreased cell death of SFs from RA joints in response to 
proapoptotic stimuli such as TRAIL could contribute to synovial 
hyperplasia and the formation of the invasive synovial tissue that 
destroys articular cartilage (52). To further explore the effects of 
Poly(I:C) EV on the apoptotic pathways in SFs, we treated SFs 
with the death receptor ligands TRAIL and FasL. Poly(I:C) EV 
decreased the TRAIL-induced apoptosis (Figures 5B,C; Figure 
S6A in Supplementary Material) and FasL-induced apoptosis 
of SFs (Figure S6B in Supplementary Material) as detected by 
Annexin V/PI apoptosis assay and Western blot measurement of 
cleaved caspase 3. Additionally, we performed a set of negative 
control experiments with Con EV and control Sup (Figures 5B,C; 
Figure S6A in Supplementary Material) as well as positive 
control experiments with Poly(I:C) transfection (Figure S5B 
in Supplementary Material), direct stimulation with Poly(I:C) 
(Figure S6C in Supplementary Material) or TNF EV (Figure S6D 
in Supplementary Material). Using these sets of experiments, 
we could exclude the possibility of antiapoptotic actions of 
contaminating soluble Poly(I:C) or U937-derived mediators and 
proposed that the observed prosurvival effects on death receptor-
induced apoptosis are a specific action of Poly(I:C) EV. Therefore, 
the amount as well as the route of Poly(I:C) delivery to a cell (as 
part of a complex EV cargo) could be crucial in regulating the bal-
ance between prosurvival and proapoptotic actions of Poly(I:C).
All in all, these results showed that Poly(I:C) EV mimic the 
proinflammatory and antiviral responses of SFs induced by direct 
stimulation with Poly(I:C), yet, have unique prosurvival effects 
on death receptor-induced apoptosis which is in contrast to the 
high toxicity of transfected Poly(I:C).
Poly(i:c) eV from PBMcs reproduce the 
Prosurvival actions of U937-cell Derived 
Poly(i:c) eV
The interactions between monocytes or monocyte-derived EV 
and SFs can modulate synovial disease pathways in inflamma-
tory arthritis (9, 52). U937 cells stimulated with TLR ligands are 
a relevant model for studying the effects of monocyte-derived EV 
in SFs (9); nevertheless, the analysis of these effects in primary 
human cells is desirable. To investigate the properties of EV from 
primary cells, we characterized the activity of EV from PBMCs 
cultured ex vivo in the presence or absence of Poly(I:C). We 
showed that PBMC-derived Poly(I:C) EV, but not Con EV or Sup 
controls, efficiently decreased TRAIL-induced apoptosis in SFs 
(Figure 5D; Figure S7A in Supplementary Material), displaying 
the antiapoptotic actions of U937 cell-derived Poly(I:C) EV. This 
finding showed that Poly(I:C) EV, derived from myeloid and/or 
lymphoid cells induced similar antiapoptotic responses in SFs, 
suggesting a general mechanism of EV, derived from these cells, 
in modulation of responses to dsRNA. Within the PBMC popu-
lation, monocytes expressed high amounts of MAC-1, whereas 
lymphocytes expressed medium amounts of MAC-1 on their 
surface (Figure S7B in Supplementary Material). Accordingly, the 
MAC-1 high peak was not present in monocyte-depleted PBMCs 
(Figure S7B in Supplementary Material). This suggested that both 
monocyte- and lymphocyte-derived EV in the EV pellets from 
PBMCs could trap or interact with Poly(I:C).
activation of the nF-kB Pathway confers 
Prosurvival actions to Poly(i:c) eV
Inhibition of NF-kB signaling can sensitize a variety of cell 
types to apoptosis induced by TRAIL (53, 54). Here we showed 
that Poly(I:C) EV efficiently activated NF-kB signaling in SFs 
in the absence or presence of TRAIL (Figures  2A and 5E,F). 
Accordingly, SFs cocultured with Poly(I:C) EV  ±  TRAIL 
clustered together based on the magnitude of NF-kB signaling 
(Figure  5E), while diverging from SFs treated with Con EV 
and/or TRAIL that clustered with untreated cells (Figure 5E). 
Next, we inhibited the NF-kB activity with sc-514, an inhibitor 
of the inhibitor of nuclear factor kappa B kinase subunit beta 
(IKBKB, also known as IKK-2). Pretreatment of SFs with sc-514 
impaired the prosurvival effects of Poly(I:C) EV during TRAIL-
induced apoptosis (Figure  5G; Figure S8A in Supplementary 
Material), thus substantiating the role for NF-kB activation in 
the prosurvival actions of Poly(I:C) EV. A strong repression 
of the TNF-driven production of IL-6 in SFs (Figure S8B in 
Supplementary Material) confirmed the efficiency of sc-514 in 
repressing NF-kB signaling in SF.
In contrast to Poly(I:C) EV, transfected Poly(I:C) (Figure 
S5B in Supplementary Material) or direct stimulation with 
Poly(I:C) (Figure S6C in Supplementary Material) had no effect 
on TRAIL-induced apoptosis of SFs. Transfected Poly(I:C) was 
highly toxic with more than 90% cell death in SFs (Figure S5B in 
Supplementary Material). Meanwhile, direct stimulation of SFs 
with Poly(I:C) can activate the NF-kB signaling (23), however, 
it also enhanced apoptosis of SFs (Figure S5A in Supplementary 
Material). Increased apoptosis of SFs in the presence of high dose 
Poly(I:C) could mask the NF-kB-dependent reduction in TRAIL-
induced apoptosis. In turn, small doses of Poly(I:C) might not 
be sufficient to activate SFs (Figures S5D,E in Supplementary 
Material) unless delivered to cells via EV (Figures 2B,C; Figures 
S5D,E in Supplementary Material).
Collectively, this indicates that Poly(I:C) EV efficiently deliver 
small amounts of Poly(I:C), which can selectively activate antivi-
ral and proinflammatory responses in SFs, the latter contributing 
to the prosurvival effects of Poly(I:C) EV during TRAIL-induced 
apoptosis.
FigUre 5 | Continued
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DiscUssiOn
Extracellular vesicles are increasingly recognized as key players in 
the immune responses to TLR activation (11, 15, 16, 45, 46). Here 
we show that EV derived from monocyte U937 cells efficiently 
shuttle the TLR3 ligand Poly(I:C) to SFs and activate Poly(I:C)-
induced signaling with enhanced proinflammatory and antiviral 
gene responses. Our experimental approach highlights the key 
importance of experimental controls that track the potential 
transfer of a stimulus [Poly(I:C)] via EV when studying the 
FigUre 5 | Extracellular vesicles (EV) derived from Poly(I:C)-stimulated U937 cells have antiapoptotic effects in synovial fibroblasts. (a) Percentage of apoptotic 
Annexin V-positive synovial fibroblasts upon treatment with U937 cell-derived EV, as measured by flow cytometry (representative flow cytometry charts are provided 
as Figure S5C in Supplementary Material). Supernatants from the last washing step of Poly(I:C) EV pellets and fetal calf serum EV control (FCS EV) were used to 
control for Poly(I:C) carryover and the effects of potential residual FCS-derived EV, respectively. (B) The cleavage of caspase 3 in synovial fibroblasts treated for 24 h 
with TRAIL ± U937 cell-derived EV. Shown is Western blot for caspase 3 and cleaved caspase 3 from one of n = 7 biological replicates with α tubulin as loading 
control. The nitrocellulose membrane from the same gel was used for detection of caspase3, cleaved caspase 3 and α tubulin with different exposure times for 
detection of each protein. Provided is merged image and the original gel images are provided as Figure S9 in Supplementary Material. Densitometry analysis of the 
cleaved caspase 3 bands was normalized to uncleaved caspase 3 bands. (c) Percentage of apoptotic Annexin V-positive synovial fibroblasts upon treatment with 
TRAIL ± U937 cell-derived EV or supernatants from the last washing step of Poly(I:C) EV pellets (supernatants), as measured by flow cytometry (representative flow 
cytometry charts are provided as Figure S6A in Supplementary Material). Shown are two different experimental setups with n = 9 and n = 16 biological replicates. (D) 
Percentage of apoptotic Annexin V-positive synovial fibroblasts, as measured by flow cytometry, upon treatment with TRAIL ± peripheral blood mononuclear cell 
(PBMC)-derived EV or supernatants from the last washing step of Poly(I:C) EV pellets (supernatants). Representative flow cytometry charts are provided as Figure S7A 
in Supplementary Material. PBMCs from healthy donors were cultured ex vivo in the presence or absence of Poly(I:C) for 16 h. Heatmap (row scaling) shows the 
clustering of TRAIL-induced apoptotic responses of synovial fibroblasts (SFs) under different experimental conditions based on the flow cytometry measurements of 
Annexin V binding. (e,F) The activity of NF-κB in synovial fibroblasts cocultured with U937 cell-derived EV ± TRAIL for 6 h, as measured by a Dual Luciferase 
Reporter Assay System. Data are expressed as the ratio of the activity of Firefly to Renilla luciferase in cells transfected with pRL_GAPDH plus pGL4.32[luc2P/
NF-κB-RE/Hygro] or pGL4.27[luc2P/minP/Hygro] vectors for 30 h. Shown are two different experimental setups: (e) a screening experiment with n = 2 biological 
replicates and (F) a confirmatory experiment with n = 6 biological replicates. (g) Percentage of apoptotic Annexin V-positive synovial fibroblasts, as measured by flow 
cytometry, upon treatment with TRAIL ± Poly(I:C) EV and/or sc-514 (50 µM), the inhibitor of IKK-2, shown are biological replicates. Representative flow cytometry 
charts are provided as Figure S8A in Supplementary Material. Statistics: (a) one-way ANOVA with Dunnett’s multiple comparisons test and Geisser–Greenberg 
correction for unequal variances (B,c,F) Friedmann ANOVA with Dunn’s multiple comparisons test (g) one-way ANOVA with Tukey’s multiple comparisons test and 
Geisser–Greenberg correction for unequal variances. ns, not significant.
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effects of stimulus-induced EV. We demonstrate that Poly(I:C) 
is present in EV released from Poly(I:C)-stimulated U937 cells 
but can also directly associate with EV in cell culture media 
from unstimulated U937 cells. These observations suggest that, 
in microenvironments (e.g., RA synovial joints) that are rich 
in extracellular RNA (20, 22) and monocyte-derived EV (55), 
extracellular RNA may directly interact with EV to become a 
bound constituent. Additionally, EV might shuttle the extracel-
lular dsRNA from the sites of generation to distant sites, thereby 
inducing proinflammatory and antiviral responses in recipient 
cells at remote locations.
The capacity of extracellular dsRNA to transcriptionally acti-
vate target genes relies on its extracellular stability and efficient 
intracellular delivery. Our experiments demonstrate that, similar 
to RNA in circulating EV, Poly(I:C) in vesicle form is stable over 
time and is rather protected from RNAse III degradation; this 
stability contrasts with the susceptibility of free Poly(I:C) to 
enzyme degradation. This finding suggests that the association of 
dsRNA with monocyte-derived EV within the proinflammatory 
milieu of RA joints could potentially protect extracellular dsRNA 
from RNase degradation. Indeed, large amounts of extracellular 
RNA are present in the RA synovium despite increased activity 
of RNases in synovial fluid from RA joints (20, 56). In turn, OA 
joints exhibit increased RNAse activity but small amounts of 
extracellular RNA (20).
The entry of Poly(I:C) into cells and the responses of cells to 
Poly(I:C) can vary with a cell type and the molecular weight of 
Poly(I:C) (57). A number of cell surface receptors such as MAC-1 
and class A scavenger receptors can participate in the extracel-
lular recognition and/or cellular uptake of Poly(I:C) (37, 50), 
clathrin-dependent endocytosis (58), and raftlin (17, 57) can also 
have essential roles in cellular internalization of Poly(I:C). We 
and others (46) provide evidence that EV can play an important 
role in the cellular entry and intercellular transfer of dsRNA. This 
ability of EV for transferring RNA has important implications for 
understanding the biology of extracellular dsRNA and developing 
new therapy, for example in the design of exosome-based antitu-
mor vaccines (45, 46, 59). dsRNA and EV seem to utilize similar 
mechanisms of cellular uptake. Clathrin and MAC-1 are present 
on neutrophil-derived EV and are involved in the internaliza-
tion of neutrophil-derived EV into platelets (60). Blocking the 
clathrin- or MAC-1-dependent uptake of neutrophil-derived EV 
by using chlorpromazine and MAC-1 antibodies, respectively, 
significantly decreases the production of TxA2 in platelets (60). 
We demonstrated that, similar to neutrophil-derived EV, U937 
cell-derived EV express MAC-1 on their surface, suggesting that 
MAC-1 might participate in EV loading and intercellular shut-
tling of Poly(I:C).
We showed that the proinflammatory and antiviral responses 
of SFs in cocultures with Poly(I:C) EV largely recapitulate the 
transcriptional activation of SFs directly stimulated with Poly(I:C) 
although TLR3 mRNA expression does not increase. The induc-
tion of MDA5 and RIG-I mRNAs upon direct stimulation of SFs 
with Poly(I:C) is much stronger compared with the induction of 
TLR3 mRNA (41). This reduced response might explain the lack 
of transcriptional activation of the TLR3 gene in SFs cocultured 
with Poly(I:C) EV, which shuttle rather a limited amount of 
Poly(I:C). In addition, EV are expected to transfer the U937-
derived molecular cargo to SFs, including DNA, RNA, protein 
and lipids as shown for a variety of other target cell–EV interac-
tions (10, 61, 62). U937 cell-derived molecules might directly 
configure fibroblast responses and might also fine-tune the 
actions of EV-delivered Poly(I:C), for example, by shuttling the 
myeloid cell-derived miR-223(63), which is predicted to target 
TLR3 mRNA (64). EV released from hepatitis B virus-infected 
HepG2 hepatocyte cells transfer virus-induced microRNA, which 
inhibit the induction of IL12p40 upon stimulation of THP-1 mac-
rophages with Poly(I:C) and CL097 (65). Additionally, Poly(I:C) 
EV might shuttle a distinct molecular cargo compared with Con 
EV, which might contribute to or independently activate SFs.
On the basis of our experiments, we argue that the antiviral 
and proinflammatory effects of Poly(I:C) EV which we describe 
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here are primarily caused by the transcriptional activation 
of SFs with EV-delivered Poly(I:C). Autologous exosomes 
released from ovarian carcinoma (HEY) cells upon Poly(I:C) 
stimulation transfer the Poly(I:C)-induced transcripts to 
Poly(I:C) naive HEY cells, thereby recapitulating Poly(I:C)-
driven cell activation (15). In contrast, we used U937 cells, a 
myeloid cell type, for EV production, but studied the effects of 
EV in SFs, a non-myeloid cell type. Myeloid and non-myeloid 
cells distinctly respond to Poly(I:C) of different molecular 
weights (57). Whereas RAW264.7 cells, THP-1 cells and 
human PBMCs are preferentially activated by low-molecular-
weight (LMW) Poly(I:C) (~1–1.5 kb), HMW Poly(I:C) (>5 kb) 
elicits strong antiviral and cytokine responses in fibroblasts 
(57). Whether EV inherit cell-type specific preference for the 
size of Poly(I:C) molecules and can thereby invoke distinct 
responses in myeloid and non-myeloid cells remains to be 
uncovered. Our experiments show that, while HMW Poly(I:C) 
increases the apoptosis of U937 cells and SFs, only SFs upregu-
late the expression of antiviral and cytokine genes. This finding 
strongly suggests that the transfer of vesicular Poly(I:C) is 
the main factor in recapitulating Poly(I:C) responses in SFs 
cocultured with Poly(I:C) EV. Similarly, dendritic cell-derived 
exosomes can cross-present TLR ligands, thereby activating the 
bystander dendritic cells (46). Furthermore, EV from virus-
infected cells shuttle viral RNA and elicit antiviral responses 
in recipient dendritic cells (66).
Extracellular vesicles share the extracellular space with solu-
ble mediators and can modulate the effects of soluble molecules 
in proinflammatory microenvironments. EV derived from the 
acute lymphoblastic leukemia (CCRF) cells modify the actions 
of the proinflammatory cytokine TNF in U937 cells, resulting 
in antagonistic, additive or synergistic effects (13). Here we 
demonstrate that U937 cell-derived Poly(I:C) EV exhibit unique 
antiapoptotic actions in SFs during death receptor-induced 
apoptosis; this action depends on the Poly(I:C) EV-driven 
activation of NF-kB. These effects cannot be induced by Con 
EV, TNF EV or Poly(I:C) alone, but can be reproduced by 
PBMC-derived Poly(I:C) EV. This suggests that the presence of 
Poly(I:C) in the complex with EV rather than a specificity of a 
cell type determines the antiapoptotic actions of Poly(I:C) EV. 
Thus, in addition to altering the cellular responses to cytokines 
(13), EV modify also the actions of extracellular dsRNA. 
Poly(I:C) EV have a unique capacity to simultaneously promote 
the proinflammatory and antiapoptotic responses in SFs. The 
antiapoptotic effects sharply contrast the high toxicity of trans-
fected Poly(I:C) and might be attributed to the route of delivery 
of Poly(I:C) (via EV), the complexing of Poly(I:C) with EV or 
the fine-tuning of Poly(I:C) actions by molecular cargo from 
U937 cells.
By their ability to transfer pathogen-associated molecular 
patterns (PAMP)-induced or DAMP-induced transcripts as well 
as PAMPs or DAMPs themselves, EV have properties consistent 
with an important role as messengers of an ongoing infection 
or tissue damage, communicating a danger signal to the host. 
Our work shows that, by shuttling dsRNA via EV, the cells of 
origin can reduce the need for an active production of danger 
signaling molecules such as proinflammatory cytokines and 
antiviral molecules. EV containing dsRNA can reproduce the 
antiviral and proinflammatory actions of dsRNA, nevertheless, 
these structures allow dsRNA to exert antiapoptotic effects on 
SFs. This unexpected inversion in the nature of dsRNA actions 
by EV might potentiate the pathogenicity of dsRNA in vivo by 
enhancing the expansion of the invasive synovial tissue in RA. 
As such, blocking the EV-dsRNA interactions could have thera-
peutic effects in arthritis. Future studies will define the contribu-
tion of EV to RA pathogenesis and effects of EV containing RNA 
in terms of proinflammatory and antiapoptotic actions.
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